Mea lako hale hana 4-Bromo-2-Fluorobenzoic Acid 4-Bromo-2-Fluorobenzoic Acid CAS 112704-79-7

No ka hoʻokō ʻana i ka ʻoluʻolu o ka poʻe kūʻai aku, ua loaʻa iā mākou kā mākou hui ikaika e hāʻawi i kā mākou kōkua nui nui e hoʻopili ai i ka hoʻolaha ʻana, ke kūʻai nui ʻana, ka hoʻolālā ʻana, ka hoʻokumu ʻana, ka mālama ʻana i ka maikaʻi kiʻekiʻe, ka hoʻopaʻa ʻana, ka hale kūʻai a me ka logistic no Factory Supply 4-Bromo-2 -Fluorobenzoic Acid 4-Bromo-2-Fluorobenzoic Acid CAS 112704-79-7, He ʻoiaʻiʻo mākou a hāmama.Manaʻo mākou i kou kipa ʻana a hoʻokumu i ka pilina kūpaʻa hilinaʻi a lōʻihi.
No ka hoʻokō ʻana i ka ʻoluʻolu i manaʻo nui ʻia e nā mea kūʻai aku, ua loaʻa iā mākou kā mākou hui ikaika e hāʻawi i kā mākou kōkua nui nui e hoʻopili ana i ka hoʻolaha ʻana, ke kūʻai nui ʻana, ka hoʻolālā ʻana, ka hoʻokumu ʻana, ka hoʻomalu maikaʻi ʻana, ka paʻi ʻana, ka hale kūʻai a me ka logistic noKina CAS 112704-79-7 a me 112704-79-7, Ua loaʻa i kā mākou mau waiwai kahi inoa maikaʻi loa ma kēlā me kēia o nā lāhui pili.No ka hoʻokumu ʻana o kā mākou ʻoihana.ua koi mākou i kā mākou hana hana hana hou me ke ʻano hana hoʻokele hou o kēia lā, e huki ana i ka nui o nā talena i loko o kēia ʻoihana.Manaʻo mākou i ka hopena maikaʻi loa e like me kā mākou ʻano mea nui loa.

Hoʻohana ʻia ʻo 1-Bromo-2-methoxy-3-nitro-benzene ma ke ʻano he waena o Eltrombopag.
ʻO Eltrombopag, i hoʻomohala ʻia e GlaxoSmithKline (GSK) ma UK a ma hope i hoʻomohala pū ʻia me Novartis ma Switzerland, ʻo ia ka mea mua a ʻae wale ʻia ka mole liʻiliʻi non peptide TPO receptor agonist ma ka honua.Ua ʻae ʻia ʻo Eltrombopag e ka US FDA ma 2008 no ka mālama ʻana i ka idiopathic thrombocytopenic purpura (ITP), a ma 2014 no ka mālama ʻana i ka anemia aplastic koʻikoʻi (AA).ʻO ia ka lāʻau lapaʻau mua i ʻae ʻia e ka US FDA no ka mālama ʻana iā AA i nā makahiki he 30 i hala iho nei.
Ma December2012, ua apono ka US FDA ia Eltrombopag no ka lapaau ana i ka thrombocytopenia i na ma'i me ka ma'i hepa C (CHC), i hiki i na ma'i hepa C me ka ilihune prognosis ma muli o ka helu platelet ha'aha'a hiki ke ho'omaka a mālama i ka interferon ma muli o ka ma'i ma'i o ka ate.Ma Feberuari 3,2014, ua hoʻolaha ʻo GlaxoSmithKline ua hāʻawi ka FDA i ka hōʻailona lāʻau lapaʻau holomua o Eltrombopag no ka mālama ʻana i ka hemopenia i nā maʻi me ka puke kemika aplastic anemia (SAA) ʻaʻole i pane piha i ka immunotherapy.Ma ʻAukake 24, 2015, ua ʻae ka US FDA iā Eltrombopag no ka mālama ʻana i ka thrombocytopenia i nā pākeke a me nā keiki o 1 makahiki a ʻoi aku me ka thrombocytopenia immune maʻi (ITP) i lawa ʻole ka pane ʻana i nā corticosteroids, immunoglobulins a splenectomy.Ma Ianuali4,2018, ua ʻae ʻia ʻo Eltrombopag e papa inoa ma Kina no ka mālama ʻana i ka thrombocytopenia immune mua (ITP).

No ka hoʻokō ʻana i ka ʻoluʻolu o ka poʻe kūʻai aku, ua loaʻa iā mākou kā mākou hui ikaika e hāʻawi i kā mākou kōkua nui nui e hoʻopili ai i ka hoʻolaha ʻana, ke kūʻai nui ʻana, ka hoʻolālā ʻana, ka hoʻokumu ʻana, ka mālama ʻana i ka maikaʻi kiʻekiʻe, ka hoʻopaʻa ʻana, ka hale kūʻai a me ka logistic no Factory Supply 4-Bromo-2 -Fluorobenzoic Acid 4-Bromo-2-Fluorobenzoic Acid CAS 112704-79-7, He ʻoiaʻiʻo mākou a hāmama.Manaʻo mākou i kou kipa ʻana a hoʻokumu i ka pilina kūpaʻa hilinaʻi a lōʻihi.
Mea lako hale hanaKina CAS 112704-79-7 a me 112704-79-7, Ua loaʻa i kā mākou mau waiwai kahi inoa maikaʻi loa ma kēlā me kēia o nā lāhui pili.No ka hoʻokumu ʻana o kā mākou ʻoihana.ua koi mākou i kā mākou hana hana hana hou me ke ʻano hana hoʻokele hou o kēia lā, e huki ana i ka nui o nā talena i loko o kēia ʻoihana.Manaʻo mākou i ka hopena maikaʻi loa e like me kā mākou ʻano mea nui loa.